EPI-HNE2

N/A

Report date: 2023/02/11 20:37:56

Base Information

Drug NameEPI-HNE2
Drug Alias NameN/A
ClassificationRadiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionRadionuclide imaging enhancersLeukocyte elastase inhibitors
TargetsLeukocyte elastase
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDyax
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDyax
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A